Literature DB >> 2567025

Behavioral effects of alpha 2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice.

M J Durcan1, R G Lister, M Linnoila.   

Abstract

The behavioral effects of two highly selective alpha 2-adrenoceptor antagonists, atipamezole and idazoxan, were investigated in mice using the plusmaze test of anxiety and the holeboard test of directed exploration and locomotor activity. No anxiogenic effect, as assessed by the tendency to enter the closed as opposed to open arms of the plusmaze, was noted for either drug at any dose tested. Neither were there any significant effects on locomotor activity or directed exploration (head-dipping) in the holeboard, or total plusmaze arm entries at any dose of either drug. The co-administration of either atipamezole or idazoxan had no effect on either the anxiolytic effect of ethanol (2 g/kg) or its locomotor stimulant effect in the holeboard. Atipamezole (1.0 and 3.0 mg/kg) significantly reversed the ethanol-induced reduction in exploratory head-dipping; a similar trend was seen for idazoxan. There was also a significant potentiation of the ethanol-induced increase in the number of total arm entries made on the plusmaze caused by 1.0 mg/kg (but not 3.0 mg/kg) atipamezole and both 0.3 and 1.0 mg/kg idazoxan. The results suggest that some of the behavioral effects of ethanol can be reversed by alpha 2-adrenoceptor antagonists whilst others are unchanged.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567025     DOI: 10.1007/BF00442248

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Autonomic and psychic effects of yohimbine hydrochloride.

Authors:  G HOLMBERG; S GERSHON
Journal:  Psychopharmacologia       Date:  1961

2.  Biphasic effects of clonidine on conflict behavior: involvement of different alpha-adrenoceptors.

Authors:  B Söderpalm; J A Engel
Journal:  Pharmacol Biochem Behav       Date:  1988-06       Impact factor: 3.533

Review 3.  The contribution of behavioural studies to the neuropharmacology of anxiety.

Authors:  S E File
Journal:  Neuropharmacology       Date:  1987-07       Impact factor: 5.250

4.  Interactions of three benzodiazepine receptor inverse agonists with ethanol in a plus-maze test of anxiety.

Authors:  R G Lister
Journal:  Pharmacol Biochem Behav       Date:  1988-07       Impact factor: 3.533

5.  Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors.

Authors:  R Dorow; R Horowski; G Paschelke; M Amin
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

6.  Time course of ethanol's effects on locomotor activity, exploration and anxiety in mice.

Authors:  M J Durcan; R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  The use of a plus-maze to measure anxiety in the mouse.

Authors:  R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Interactions of alpha 2-adrenoceptor antagonists with medetomidine and with ethanol in a holeboard test.

Authors:  M J Durcan; R G Lister; M Linnoila
Journal:  Neuropharmacology       Date:  1989-03       Impact factor: 5.250

9.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

10.  Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.

Authors:  D S Charney; G R Heninger; D E Redmond
Journal:  Life Sci       Date:  1983-07-04       Impact factor: 5.037

View more
  10 in total

1.  Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study.

Authors:  Carolina L Haass-Koffler; Lorenzo Leggio; Dena Davidson; Robert M Swift
Journal:  Alcohol Clin Exp Res       Date:  2015-04       Impact factor: 3.455

Review 2.  Noradrenergic targets for the treatment of alcohol use disorder.

Authors:  Carolina L Haass-Koffler; Robert M Swift; Lorenzo Leggio
Journal:  Psychopharmacology (Berl)       Date:  2018-02-20       Impact factor: 4.530

3.  Differential effects of catecholamine antagonists on ethanol-induced excitation in mice.

Authors:  U M Koechling; B R Smith; Z Amit
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist.

Authors:  Antti Pertovaara; Antti Haapalinna; Jouni Sirviö; Raimo Virtanen
Journal:  CNS Drug Rev       Date:  2005

5.  Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.

Authors:  C J McDougle; J H Krystal; L H Price; G R Heninger; D S Charney
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

6.  Behavioral effects of the inhibitors of phenylethanolamine-N-methyltransferase, LY 78335 and LY 134046, and their interactions with ethanol.

Authors:  M J Durcan; R G Lister; M Linnoila
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Idazoxan increases rough-and-tumble play, activity and exploration in juvenile rats.

Authors:  S M Siviy; D M Atrens; J A Menendez
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Interactions of intracerebroventricular pertussis toxin treatment with the ataxic and hypothermic effects of ethanol.

Authors:  M J Durcan; R G Lister; P F Morgan; M Linnoila
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

9.  Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.

Authors:  J C Cole; G J Burroughs; C R Laverty; N C Sheriff; E A Sparham; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

10.  Central norepinephrine transmission is required for stress-induced repetitive behavior in two rodent models of obsessive-compulsive disorder.

Authors:  Daniel Lustberg; Alexa F Iannitelli; Rachel P Tillage; Molly Pruitt; L Cameron Liles; David Weinshenker
Journal:  Psychopharmacology (Berl)       Date:  2020-04-20       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.